Literature DB >> 25386236

A case of rheumatic fever with acute post-streptococcal glomerulonephritis and nephrotic syndrome caused by a cutaneous infection with beta-hemolytic streptococci.

Carsten Sauer Mikkelsen1, Allan Gelvan1, Ahmad Ibrahim2, Karin Ladefoged1.   

Abstract

Entities:  

Keywords:  acute post-streptococcal glomerulonephritis; nephrotic syndrome.; rheumatic fever

Year:  2010        PMID: 25386236      PMCID: PMC4211464          DOI: 10.4081/dr.2009.e4

Source DB:  PubMed          Journal:  Dermatol Reports        ISSN: 2036-7392


× No keyword cloud information.

Case Report

A 44-year old woman of Greenlandic origin was referred to Queen Ingrid’s Hospital. She was previously healthy apart from excessive alcohol consumption and pulmonary tuberculosis diagnosed two years earlier for which she had received full antimycobacterial treatment. The patient initially complained of a painful traumatic skin lesion of the right lower extremity with a diameter of approximately 2 cm. A few days later, her temperature rose to 39.5°C and bullous erysipelas of the area of initial trauma was noted. Laboratory tests revealed a markedly elevated sedimentation rate of 111 mm/L hour [2-21], an elevated C reactive protein of 144 mg/L [<10], leukocytosis 18×109/L [4.4–11] with neutrophilia and ×10>9/L [150-450]. Intravenous dicloxacillin and phenoxymethylpenicillin were administered. Culture from the lesion of the right lower extremity was positive for group A β-hemolytic streptococci (GABHS). In spite of relevant antibiotic treatment, the clinical condition rapidly deteriorated with involvement of the deeper layers of the skin and subcutaneous tissue, spreading across the fascial planes of the subcutis (Figure 1). Necrotizing fasciitis (NF) was diagnosed. Based on positive skin cultures, this condition was considered to be due to GABHS. The patient had no other predisposing factors to NF, specifically no diabetes mellitus, no intravenous abuse and no daily intake of non-steroidal anti-inflammatory drugs (NSAID). Radiological examination of the right lower extremity and foot showed no signs of osseous involvement. Extensive surgical revision of the NF-lesion was performed and meropenem, ciprofloxacin and clindamycin were administered. Approximately three weeks after the initial presentation, impairment of renal function with azotemia and severe nephrotic syndrome with periorbital and peripheral edema were noted. Laboratory tests showed an elevated creatinine of 386 umol/L [44-115], BUN: 23.6 mmol/L [2.5–6.7], normochromic, normocytic anemia with hemoglobin: 4.9 mmol/L [7.5–9.0], as well as macroscopic hematuria, renal-creatinine clearance: 30 mL/min and U-protein: 5.8 g/24 h [<0.15]. Anti nuclear antibodies (ANA), anti-neutrophil cytoplasmic antibodies (ANCA), IgA, IgG, IgM and protein electrophoresis were all normal. Blood pressure was increased to 165/100. The hypertension was efficiently treated by ACE-inhibitors and beta blockers. The patient was transferred to Rigshospitalet, Copenhagen where a renal biopsy was performed. The biopsy demonstrated endocapillary glomerulonephritis with proliferation of endothelial cells and infiltration of polymorphonuclear cells. Using immunofluorescence techniques, granular deposits of IgG and C3 were identified as typically seen in acute post-streptococcal glomerulonephritis (APSGN) (Figure 2). During the same period, the patient complained of chest pain. Electrocardiogram (ECG) showed sinus rhythm with no signs of ischemia and no elevation of cardiac troponin I was found. Echocardiography showed moderate reduced left ventricular ejection fraction (LVEF): 35% [50–65%] and moderate mitral regurgitation (grade II). Pulmonary pressure was significantly increased > 60 mm Hg [18-25]. Brain natriuretic peptide (BNP) was significantly increased >8000 pg/mL [<100]. There were complaints of arthralgia of the left elbow. There were no other signs of acute rheumatic fever (ARF) and no signs of pharyngitis in the whole period. Chest X ray and HR-CT of the thorax showed changes in both lungs consistent with old tuberculosis. Two weeks after the first analysis, renal function had improved and U-protein had decreased to 2.6 g/24 h, creatinine 139 umol/L, BUN 9.5 mmol/L. Ultrasound of the kidneys was normal. Echocardiography still showed moderate reduced left ventricular ejection fraction (LVEF): 35% with mild mitral regurgitation (grade I). Continued follow-up of renal and cardiac function is planned.
Figure 1

Group A β-hemolytic streptococci with involvement of the deeper layers of the skin and subcutaneous tissue, spreading across the fascial planes of the subcutis.

Figure 2

Diffuse proliferative glomerulonephritis with approximately 40% halfmoons. Significant tubulus atrophy and interstitial fibrosis with inflammation. Endocapillary glomerulonephritis, with accumulation of endothelial cells and inflammatory cells in the capillary lumina. Changes compatible with acute post-streptococcal glomerulonephritis. No signs of systemic disease or vasculitis.

Group A β-hemolytic streptococci with involvement of the deeper layers of the skin and subcutaneous tissue, spreading across the fascial planes of the subcutis. Diffuse proliferative glomerulonephritis with approximately 40% halfmoons. Significant tubulus atrophy and interstitial fibrosis with inflammation. Endocapillary glomerulonephritis, with accumulation of endothelial cells and inflammatory cells in the capillary lumina. Changes compatible with acute post-streptococcal glomerulonephritis. No signs of systemic disease or vasculitis.

Discussion

This case illustrates the simultaneous development of carditis, arthralgia and endocapillary glomerulonephritis with severe nephrotic syndrome preceded by a cutaneous GABHS in the lower right leg. The patient fulfils the revised and updated Jones criteria for classification of ARF based on fever, arthralgia, carditis, increased acute phase reactants (CRP, ESR) and a positive culture of GABHS. ARF develops after group A streptococcal pharyngitis[1,2] and is only seldom described after GABHS skin infections.[3-5] Our patient had no signs of pharyngitis but developed NF presumably from a traumatic skin lesion. Culture from the initial lesion of the right lower extremity was positive for GABHS.We propose that our patient developed ARF from her skin infection. We are aware of no history of sore throat described in the literature in cases of ARF.[6] Also throat swab will be positive in only a third of patients infected with group A streptococcus before antibiotic treatment and in only a tenth of patients afterwards.[7] GAS pyoderma rather than pharyngitis as a driving force behind ARF has been described in aboriginal communities in Northern Australia.[8,9] Repeated exposure to GABHS can play a central role in the development of ARF[10] as a sort of immune priming.[8] In our case there was no previous history of pharyngitis or other focus of GABHS infections. ARF and APSGN, two important sequelae of streptococcal throat or skin infections, according to current concepts may be elicited by autoimmune mechanisms due to molecular mimicry between GABHS and human tissue.[11] APSGN follows infection with a limited number of GABHS serotypes. Type 12 is the most frequent M serotype causing APSGN after pharyngitis or tonsillitis, whereas M-49 is the type most frequently related to pyoderma-associated nephritis.[12] The patient had no earlier symptoms of heart disease and so we strongly suspect the high BNP and and moderate mitral regurgitation to be carditis related to ARF. In affluent societies where GABHS disease is uncommon apart from pharyngitis in childhood, increasing numbers of NF and streptococcal toxic shock syndrome (STSS) have been seen, as well as an upsurge of acute rheumatic fever apparently restricted to parts of the United States.[13-16] In some of these locations, a virulent M1 serotype GABHS clone has been found.[17] We suggest a possible relation between a virulent GABHS clone causing NF and ARF.
  17 in total

1.  Grand rounds in rheumatology: acute rheumatic fever or post-streptococcal reactive arthritis: a clinical problem revisited.

Authors:  T L Jansen; M Janssen; P L van Riel
Journal:  Br J Rheumatol       Date:  1998-03

Review 2.  Molecular basis of group A streptococcal virulence.

Authors:  A L Bisno; M O Brito; C M Collins
Journal:  Lancet Infect Dis       Date:  2003-04       Impact factor: 25.071

Review 3.  Differences between streptococcal infections of the throat and of the skin (second of two parts).

Authors:  L W Wannamaker
Journal:  N Engl J Med       Date:  1970-01-08       Impact factor: 91.245

4.  Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study.

Authors:  R Kaul; A McGeer; D E Low; K Green; B Schwartz
Journal:  Am J Med       Date:  1997-07       Impact factor: 4.965

Review 5.  Skin infections and infestations in Aboriginal communities in northern Australia.

Authors:  B J Currie; J R Carapetis
Journal:  Australas J Dermatol       Date:  2000-08       Impact factor: 2.875

6.  Clinical experience with 20 cases of group A streptococcus necrotizing fasciitis and myonecrosis: 1995 to 1997.

Authors:  C T Haywood; A McGeer; D E Low
Journal:  Plast Reconstr Surg       Date:  1999-05       Impact factor: 4.730

7.  Myocardial tissue damage in rabbits injected with group A streptococci, types M1 and M22. Role of bacterial immunoglobulin G-binding surface proteins.

Authors:  L A Burova; V A Nagornev; P V Pigarevsky; M M Gladilina; E A Gavrilova; V G Seliverstova; A A Totolian; A Thern; C Schalén
Journal:  APMIS       Date:  2005-01       Impact factor: 3.205

8.  Molecular typing of Streptococcus pyogenes from remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infection.

Authors:  M I McDonald; R J Towers; P Fagan; J R Carapetis; B J Currie
Journal:  Epidemiol Infect       Date:  2007-02-19       Impact factor: 2.451

9.  Echocardiographic diagnosis of subclinical carditis in acute rheumatic fever.

Authors:  N J Wilson; J M Neutze
Journal:  Int J Cardiol       Date:  1995-06-02       Impact factor: 4.164

10.  The dynamic nature of group A streptococcal epidemiology in tropical communities with high rates of rheumatic heart disease.

Authors:  M I McDonald; R J Towers; R Andrews; N Benger; P Fagan; B J Currie; J R Carapetis
Journal:  Epidemiol Infect       Date:  2007-05-31       Impact factor: 2.451

View more
  1 in total

1.  Case Report: Concurrent Rheumatic Fever and Acute Post-Streptococcal Glomerulonephritis in a High-Burden Setting.

Authors:  Anna V Nakauyaca; Anna P Ralph; William S Majoni; Nadarajah Kangaharan
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.